Press Release – Stiris’ Shantal Feltham Receives YMCA Women of Excellence in Entrepreneurship

February 8, 2019 | Stiris

We are pleased to announce that the President and CEO of Stiris Research, Shantal Feltham, is the recipient of the 2019 Women of Excellence Award in Entrepreneurship. This award, presented every 2 years, honours women who have contributed to the growth of their community, and whose accomplishments inspire others to achieve their goals. Shantal’s passion, […]


Stiris Research Inc. completes enrollment ahead of schedule on a Phase 1b Uveal Melanoma study

January 14, 2019 | Stiris

London, ON – January 14th, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announced successfully completing enrollment ahead of the Australian biotech’s corporate milestone target on their Phase 1b Open label study in Uveal Melanoma metastatic to liver. The last patient was screened […]


Stiris Research Inc. announces addition of Executive Director, Sales & Marketing

January 7, 2019 | Stiris

Cambridge, MA – January 7th, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce the addition of Glenn Block to its Business Development team. Glenn Block joins the company as the Executive Director, Sales & Marketing and brings 20+ years’ commercial experience in […]


Stiris Research Inc. announces completion of Site Closeout Visits in their Phase II Hormone Refractory Castrate-Resistant Prostate Cancer (HRCPC) study

May 24, 2018 | Stiris

London, ON – May 24, 2018 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announces the completion of all 10 Closeout Visits (COVs) of North American Investigative Sites who participated in the extension phase of a Phase II Hormone-Refractory Castrate-Resistant Prostate Cancer (HRCPC) study. […]


Stiris Research Inc. announces the completion of Site Closeout Visits for its Phase III trial in Parkinson’s Disease

March 23, 2018 | Stiris

London, ON – March 23, 2018 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announced the completion of 84 Investigative Site closeout visits (COVs) for a global Phase III trial in Parkinson’s Disease (PD). “We are very proud of our team’s accomplishment and for […]


Stiris Research Inc. completes database lock on Phase III Global Parkinson’s trial

February 22, 2018 | Stiris

London, ON – February 22nd, 2018 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announced that they have successfully completed the database lock ahead of schedule  for a US client on their global Phase III trial in Parkinson’s disease trial. “Stiris stepped up to […]


Stiris Research Inc. hits corporate target of First Patient First Visit on Phase 1b Uveal Melanoma study

February 2, 2018 | Stiris

London, ON – February 2nd, 2018 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announces successfully achieving an Australian biotech’s corporate milestone target of First Patient First Visit (“FPFV”) in their Phase 1b Open label study in Uveal Melanoma metastatic to liver. Stiris is […]


Stiris Research Inc. awarded Phase Ib trial in Uveal Melanoma

November 7, 2017 | Stiris

London, ON – November 7th, 2017 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announces they have entered into a Master Services Agreement (the “MSA”) with an Australian biotechnology company.  Under the terms of the MSA, Stiris is excited to announce that it will […]


Stiris Research Inc. completes Phase II Meniere’s disease study

September 26, 2017 | Stiris

London, ON – September 26, 2017 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announces that it has completed and closed a US biotechnology company’s Phase II Meniere’s disease study. “Our Canadian sites all achieved great success on this study and allowed the sponsor […]


Stiris Research Inc. collaborates on a Investigator Initiated Trial in Frontotemporal Dementia

August 17, 2017 | Stiris

London, ON – August 17, 2017 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announced its collaboration with a London, ON hospital and Investigator on their North American Phase II Investigator Initiated trial in Frontotemporal Dementia. “Collaborating and working alongside a local medical and […]